Search by...
-
9JulTransparency in clinical trials: Revised transparency rules take effectThe revised transparency rules (“Revised Rules”) for the Clinical Trials Regulation (CTR) and its Clinical Trials Information System (CTIS), issued by the EMA in October 2023, took effect on June 28, 2024, with the launch of a new version of the dedicated portal
-
2JulAI and healthcare: A question of responsibility and liabilityArtificial intelligence (AI) systems of varying levels of sophistication are increasingly used in health care in conjunction with various medical services.
-
11JunMedical research: Prior consultation with the Data Protection Authority is no longer requiredMedical research is one of the areas most affected by rapid technological development and increased use of artificial intelligence (AI) systems.
-
23MayOnline medicine sales and the processing of purchase data: The Court of Justice of the European Union rulesData related to purchasing non-prescription medicine sold online by an authorized pharmacy should not be considered health-related data under the GDPR.
-
10MayArtificial Intelligence in health care: Impact of the new draft law approved by the Italian Council of MinistersThe Italian Council of Ministers approved a draft law on principles governing artificial intelligence, designed to provide an initial national framework for artificial intelligence systems.
-
6MayHow Digital Procurement Platforms (PADs) change procurementAmong the main types of infrastructure needed to achieve full digitization of public procurement are Digital Procurement Platforms, or “PADs.” On January 1, 2024, the provisions of the new Public Procurement Code on the digitization of tender procedures became fully effective.
-
26AprItalian Data Protection Authority publishes rules for platforms (websites or apps) connecting patients and healthcare professionalsIn recent years, technology has revolutionized many sectors, including healthcare. Online platforms and apps that connect patients with healthcare professionals have made medical care more accessible, especially in settings where physical presence is limited or not possible. This evolution has also raised important issues concerning privacy and the protection of personal data.
-
17AprPortolano Cavallo announces the appointment of Alessandro Tanno as partnerWith Alessandro Tanno's appointment, the number of partners rises to 21
-
9AprChatbots and virtual assistants: How might they be used in pharmaceuticals?The pharmaceutical sector is not immune to the paradigm shift in user/patient relations, connected to the development and implementation of artificial intelligence systems: when browsing the web and using smartphone applications, users increasingly encounter chatbots and virtual assistants that interact with them.
-
9Apr“Pharmacy of Services”: Simplification Decree expands the range of healthcare and telemedicine services pharmacies can provideThe new draft of the Simplification Decree, recently approved by the Council of Ministers, significantly expands the range of services that can be provided by pharmacies as part of the National Health Service.